Methods for the treatment of glaucoma are provided by the present invention. The compounds described cause a perturbation of the actin cytoskeleton in the trabecular meshwork or the modulation of its interactions with the underlying membrane. Perturbation of the cytoskeleton and the associated adhesions...http://www.google.es/patents/US6586425?utm_source=gb-gplus-sharePatente US6586425 - Cytoskeletal active agents for glaucoma therapy
